Purchase Order 75N98026P00607

This federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Rush University Medical Center, a non-profit academic medical center based in Chicago, Illinois. The contract is for $23,835.50 to provide genetic sequencing services. It is a firm fixed-price purchase order with an ultimate completion date of August 25, 2025. The contract does not have a set-aside designation. Rush University Medical Center has a record of securing various federal contracts and...

This is a federal contract award from the National Institutes of Health (NIH) Clinical Center to Rush University Medical Center, a non-profit academic medical center in Chicago, Illinois. The contract is for $26,933.50 and is a firm fixed-price purchase order for sample analysis services, with a completion date of September 25, 2026. The contract is not set aside for any specific business type. Rush University Medical Center has an existing indefinite-delivery/indefinite-quantity (IDIQ) multiple...

<p>The NIH Clinical Center awarded a purchase order to Corebiome, Inc. for $13,761.00 on June 24, 2020, to measure microbiome in quality control standards using 16S ribosomal RNA and shotgun sequencing. Performance takes place in Rockville, Maryland. The order carries a firm fixed price structure with no small business set-aside and is scheduled for completion by January 1, 2021.</p>

This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 12 (VISN 12) to Rush University Medical Center, a non-profit hospital and academic medical center based in Chicago, Illinois. The contract, valued at $55,242.70, is for RNA isolation services with the Genomics and Microbiology Core Facility (GMCF) at Rush University. The contract has an ultimate completion date of September 29, 2026. Rush University Medical Center, which does business as Rush...

The NIH Clinical Center awarded a $12,298.50 firm fixed price purchase order to 10X Genomics, Inc. on September 17, 2025, for reagents supporting microbiome research experiments under the FY26 Unmet Data Opportunity (UDO) Initiative. The contract, which carries no set-aside designation, is scheduled for completion by October 18, 2025, with performance at 10X Genomics' headquarters in Pleasanton, California. This purchase order represents a direct procurement of specialized genomic analysis...

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $19,814.32 on January 14, 2020, with final completion on February 21, 2020. The order is firm fixed price with no set-aside designation. Work is performed at the NIH Clinical Center in Bethesda, Maryland. The source does not specify the items or services procured under this order.</p>

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $160,371.00 on May 31, 2026, for firm fixed-price procurement of genetic sequencing equipment, reagents, or related consumables. No set-aside was used. Work is performed in San Diego, California. The order is scheduled for completion by May 30, 2027.</p>

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc., valued at $6,418.66, on March 6, 2018. The order was de-obligated on March 16, 2018. Work is performed in Bethesda, Maryland. The purchase order is firm fixed price with no set-aside designation and procures Illumina's genetic sequencing and genomic analysis products or services in support of the NIH Clinical Center's research operations.</p>

<p>The NIH Clinical Center awarded a purchase order to Life Technologies Corporation valued at $363,228.02 on July 24, 2018, for a firm fixed price award with no set-aside designation. Place of performance is Bethesda, Maryland. The order is scheduled for ultimate completion on December 31, 2020. The source does not specify the goods or services procured.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $30,158 firm fixed price purchase order to 10X Genomics, Inc. for 10X Genomics reagents. The place of performance will be 10X Genomics' facilities in Pleasanton, California, with work occurring between July 7, 2023 and September 30, 2023. As the intramural clinical and research program of the NIH, the NIH Clinical Center supports the mission of the NIH to uncover new knowledge that will lead to...